Abstract: The invention relates to monoclonal antibodies, in particular against a peptide of the BAMBI protein, as well as the uses thereof and methods comprising same. Preferably, the antibodies are used for the treatment of autoimmune diseases.
Type:
Application
Filed:
November 30, 2016
Publication date:
November 7, 2019
Applicants:
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTICAS (CSIC), UNIVERSIDAD DE CANTABRIA